Taiwan Biotech Companies in Potential Merger/Acquisition Deals: An Analysis Based on Trends of Global Merger/Acquisition Deals Among International Pharmaceutical Companies
碩士 === 國立臺灣大學 === 財務金融組 === 105 === There are two major exit strategies for biotech company shareholders in the global market. The first one is IPO; which allows investors to sell their shares in the open market. The other is via merger/acquisition, selling the whole company to a larger biotech and/...
Main Authors: | Ching-Fen Kuo, 郭靜芬 |
---|---|
Other Authors: | 邱顯比 |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/23581379147328260912 |
Similar Items
-
Mergers and acquisitions in the pharmaceutical and biotech industries
by: Ireland, John M. (John Mathias), 1964-
Published: (2005) -
The Deal Protection Measures of Mergers and Acquisitions
by: LIN, I-FAN, et al.
Published: (2018) -
The Effect of Public-Listed Companies’ Merger and Acquisition Deal Announcement on the Stock Price in Taiwan
by: Liu, Chia-Ling, et al.
Published: (2018) -
The Choice of Acquirer's Advisor and the Deal Premium in Mergers and Acquisitions
by: Chia Yu Liu, et al.
Published: (2009) -
Chinese companies' cross-border mergers and acquisitions performance : evidence from inward and outward deals
by: Sun, Miao
Published: (2018)